BofA Maintains Underperform Rating on GoodRx (GDRX) While Trimming PT to $2.60

Additionally, Morgan Stanley reduced its price target for GoodRx from $5 to $4 while maintaining an Equal Weight rating on ...

Scotiabank Downgrades AST SpaceMobile (ASTS) to Underperform, Calling Valuation “Irrational” with $45.60 PT

AST SpaceMobile Inc. (NASDAQ:ASTS) is one of the hot tech stocks to invest in. On January 7, Scotiabank downgraded AST ...
Nasdaq

Eversource downgraded to Underperform from Sector Perform at Scotiabank

Scotiabank downgraded Eversource (ES) to Underperform from Sector Perform with a price target of $56, down from $66. The theme of 2025 will be the robust outlook for demand for electricity, which the ...
Hosted on MSN

Lineage downgraded to Underperform as BofA sees demand headwinds continuing

Bank of America Securities on Monday downgraded Lineage (NASDAQ:LINE) stock to Underperform from Neutral as analyst Samir Khanal cited a tough sector-wide demand environment in the face of ...

AST Spacemobile stock falls after Scotiabank downgrade to Underperform

Despite acknowledging AST Spacemobile’s "highly disruptive" technology with potential for dual use, Coello maintained that the company’s multi-year delays and Starlink’s rapid growth justify a ...
Seeking Alpha

NNN REIT downgraded to Underperform at BNP amid cloudy tenant outlook

BNP Paribas downgraded NNN REIT (NYSE:NNN) to Underperform from Neutral as uncertainty surrounding troubled tenants continue to cloud the outlook for the net-lease REIT. Management mentioned the same ...
Seeking Alpha

E2open moved to Underperform at BofA as company misses out on industry growth

E2open (NYSE:ETWO) was in the spotlight on Wednesday as Bank of America moved its rating on the cloud software company to Underperform from No Rating, noting it has missed out on industry growth. The ...
Hosted on MSN

Berkshire downgraded to Underperform from Market Perform at Keefe Bruyette

Keefe Bruyette downgraded Berkshire Hathaway (BRK.B) (BRK.A) to Underperform from Market Perform with a price target of $7,000, down from $735,000. The firm believes the peaking of Geico’s ...